I was expecting a reacceleration of growth for UiPath in the second half of FY2023 — management expects otherwise. Short-term macro uncertainty and weaker-than-expected guidance led to investors ...

Initiate on UiPath Inc. at Neutral with a $15 PT, citing resilient cloud ARR growth and enterprise customer expansion, but competitive intensity and CEO transition limit near-term upside. FY26E and ...

UiPath Inc. (NYSE: PATH) was recently added to the S&P MidCap 400 index, replacing Synovus Financial Corp., reflecting the automation company's increased scale and market presence. This index ...

Palantir’s revenue accelerated again as its profits soared. UiPath’s growth stalled out as it faced macro and competitive challenges. The pricier stock should be the better buy for the foreseeable ...

UiPath (NYSE: PATH) is a tiny company compared to Microsoft. The stock of the maker of robotic process automation (RPA) software is only worth $7.2 billion, while the diversified tech titan is worth a ...

Gupta provided Q2 2026 guidance of revenue in the range of $345 million to $350 million and ARR in the range of $1.715 billion to $1.720 billion. Full fiscal year 2026 guidance is revenue of $1.549 ...

UiPath (NYSE:PATH) just delivered a quarterly earnings report that turned more than a few heads. The company posted revenue growth and impressive gross margins, which caught the attention not just of ...

In early December 2025, UiPath reported third-quarter revenue of US$411.11 million and net income of US$198.84 million, marking a shift from a loss a year earlier and issuing new fourth-quarter ...

Palantir (NYSE: PLTR) and UiPath (NYSE: PATH) represent two different ways to invest in the growing artificial intelligence (AI) market. Palantir mines data from disparate sources to help its ...